Axe Compute (NASDAQ: AGPU) Completes Corporate Restructuring (formerly POAI), Enterprise-Grade Decentralized GPU Computing Power Aethir Officially Enters Mainstream Market
Predictive Oncology has officially rebranded as Axe Compute (NASDAQ: AGPU), marking its transition into commercializing Aethir’s decentralized GPU network to provide enterprise-grade, guaranteed computational power for global AI companies. The core infrastructure is supported by the Aethir Strategic Compute Reserve (SCR), which offers predictable GPU reservations, dedicated computing clusters, and enterprise-level SLAs to address AI training, inference, and data-intensive workload demands.
This move represents the first time decentralized GPU infrastructure has entered mainstream capital markets via a U.S. publicly listed company. Axe Compute will serve as the enterprise-facing entity, delivering compliant and scalable computational resources, while Aethir continues to power the underlying decentralized GPU-as-a-Service infrastructure. The structure bridges Web3 decentralized networks with Web2 enterprise needs, allowing businesses to utilize distributed GPU resources within familiar procurement and compliance frameworks.
Aethir’s network currently spans 93 countries and over 200 regions, with more than 435,000 GPU containers deployed, supporting high-end hardware like NVIDIA H100, H200, B200, and B300. Axe Compute’s model aims to mitigate industry challenges such as long GPU procurement cycles, centralized cloud queuing, and pricing volatility by offering reserved GPU access, bare-metal performance, multi-region deployment, and enterprise SLAs.
This listing is seen as a significant milestone in scaling decentralized AI infrastructure into enterprise markets, providing a publicly evaluable model for the commercial adoption of distributed computational resources.
marsbit12/12 13:35